Literature DB >> 35444011

Covid-19: Has the spread of omicron BA.2 made antibody treatments redundant?

Elisabeth Mahase1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35444011     DOI： 10.1136/bmj.o1009

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Omicron BA.2 Lineage, the "Stealth" Variant: Is It Truly a Silent Epidemic? A Literature Review.

Authors:  Giorgio Tiecco; Samuele Storti; Stefania Arsuffi; Melania Degli Antoni; Emanuele Focà; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 2.  A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.

Authors:  Yasser Mohamed; Yousra A El-Maradny; Ahmed K Saleh; AbdElAziz A Nayl; Hamada El-Gendi; Esmail M El-Fakharany
Journal:  Biomed Pharmacother       Date:  2022-08-02       Impact factor: 7.419

3.  WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.

Authors:  Mary Y Wu; Edward J Carr; Ruth Harvey; Harriet V Mears; Svend Kjaer; Hermaleigh Townsley; Agnieszka Hobbs; Martina Ragno; Lou S Herman; Lorin Adams; Steve Gamblin; Michael Howell; Rupert Beale; Michael Brown; Bryan Williams; Sonia Gandhi; Charles Swanton; Emma C Wall; David L V Bauer
Journal:  Lancet       Date:  2022-10-06       Impact factor: 202.731
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.